Need advice in managing cancer immunotherapy cardiotoxicity?

Request Assistance

FDA Public Workshop: Assessment of Cardiovascular Toxicities in Immuno-oncology Trials
Posted by Moslehi on January 22, 2018

On Friday, December 1, 2017, the U.S. Food & Drug Administration (FDA) announced a public workshop entitled, “Assessment of Cardiovascular Toxicities in Immuno-oncology Trials”. This workshop provided a forum for discussion of cardiovascular toxicities in immuno-oncology clinical trials. The workshop focused on the identification...

Read More
Manuscripts published in Circulation raise awareness for immune checkpoint inhibitor associated myocarditis
Posted by Moslehi on January 22, 2018

Two manuscripts published on November 21, 2017 of the journal Circulation bring additional awareness for the syndrome of immune checkpoint-inhibitor (ICI)-associated myocarditis. Thuny and colleagues (Hospital Nord, Marseille, France) present a case series of 30 patients with ICI-induced cardiotoxicity. Cardiotoxicity was diagnosed at a...

Read More
Cardio-Oncology highlighted at American Heart Association Annual Meeting 2017
Posted by Moslehi on January 22, 2018

There were several cardio-oncology sessions at the American Heart Association (AHA) annual meeting which occurred in November 2017 in Anaheim, California. A session called “The Emerging Science of Cardio-Oncology” focused on the rapidly evolving area of clinical practice in cancer patients with heart failure or acute coronary...

Read More
View All
connect with us

Nice overview published in @TheLancetOncol:

“Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.”

@CardioOncology @MGHCancerCenter #Immunotherapy #ImmunoOnc @TheLancet

Looking forward to Vanderbilt #CardioOnc conference this week. Great to have world expert Dr. Doug Johnson discuss cancer immunoRx! @VUMC_heart @VUMChealth @KimrynRathmell @drbrowncares @OSUCardioOnc @EuroCardioOnc @CastrillonJess @AHAScience @escardio @arjunkg @FredRiveraMD

Nice tribute to Dr. Keith Churchwell @KChurchwellMD at @VUMC_heart cardiology faculty meeting this morning. To my colleagues at @YNHH @YaleCardiology @YaleCVRC @ericjvelazquez @yaleHFdoc remember: he may be a Yalie now but he always remembers where it all started! @VUMChealth

Great leadership by Doug Johnson & great collaboration w/ @BalkoLab @DrJNaidoo @cappelliMD @MGHCancerCenter. Understanding IO toxicity will require a team effort & A+ internal medicine group! @KimrynRathmell @TheLancetOncol @Bob_Wachter @thomasjwang1